返回
Matrix Factorization-based Technique for Drug Repurposing Predictions
DOI:10.1109/JBHI.2020.2991763.png)
摘要
En 中文
Classical drug design methodologies are hugely costly and time-consuming, with approximately 85% of the new proposed molecules failing in the first three phases of the FDA drug approval process. Thus, strategies to find alternative indications for already approved drugs that leverage computational methods are of crucial relevance. We previously demonstrated the efficacy of the Non-negative Matrix Tri-Factorization, a method that allows exploiting both data integration and machine learning, to infer novel indications for approved drugs. In this work, we present an innovative enhancement of the NMTF method that consists of a shortest-path evaluation of drug-protein pairs using the protein-to-protein interaction network. This approach allows inferring novel protein targets that were never considered as drug targets before, increasing the information fed to the NMTF method. Indeed, this novel advance enables the investigation of drug-centric predictions, simultaneously identifying therapeutic classes, protein targets and diseases associated with a particular drug. To test our methodology, we applied the NMTF and shortest-path enhancement methods to an outdated collection of data and compared the predictions against the most updated version, obtaining very good performance, with an Average Precision Score of 0.82. The data enhancement strategy allowed increasing the number of putative protein targets from 3,691 to 15,295, while the predictive performance of the method is slightly increased. Finally, we also validated our top-scored predictions according to the literature, finding relevant confirmation of predicted interactions between drugs and protein targets, as well as of predicted annotations between drugs and both therapeutic classes and diseases.
Keyword:
Drugs
Diseases
Proteins
Matrix decomposition
Protein engineering
Chemicals
Complex networks
drug repurposing
drug repositioning
link prediction
non-negative matrix tri-factorization
shortest-paths
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
6.8
论文数:
4.6K
被引数:
2.0W
机构
引用论文
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository基因表达综合: NCBI基因表达和杂交阵列数据库
NUCLEIC ACIDS RESEARCH
IF13.1
Quantitative Performance Evaluation of Uncertainty-Aware Hybrid AADL Designs Using Statistical Model Checking使用统计模型检查对不确定性感知的混合AADL设计进行定量性能评估
Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics
NUCLEIC ACIDS RESEARCH
IF13.1

